TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Thermo Fisher Scientific, Inc. Q1 2010 Earnings Call Transcript Thermo Fisher Scientific, Inc. (TMO)Q1 2010 Earnings CallApril 28, 2010 8:30 AM ETComplete Story » seekingalpha.com |
Adolor's Pain Continues as Osteoarthritis Drugs Fail in Trial EP Vantage submits:Sometimes it does not just rain it pours. For Adolor (ADLR), this week has been a very stormy affair. First it announced Thursday that both its novel opioid drugs, ADL5859 and ADL5747, failed in a phase IIa osteoarthritis (OA) trial. Friday, this failure was further compounded by the fact that Pfizer’s (PFE) own OA drug tanezumab, a monoclonal antibody, had succeeded in phase III trials. Shares in Adolor reacted to the poor trial outcomes of ADL5859 and ADL5747 by dipping 15% Friday to $1.28, a five-year low. This leaves the company with a market value of $59.3m, below current cash levels of about $73m, and question marks hanging overhead, about whether Adolor could now be a suitable takeout target for a cash-hungry company.Complete Story » seekingalpha.com |
Panelist Who Backed Avandia Gets Fees From Glaxo One of the panelists who voted in favor of the diabetes drug Avandia at an FDA advisory meeting last week is a paid speaker for the drug's maker, Glaxo. online.wsj.com |
Quest Diagnostics Marks Seventh Year on Dow Jones Sustainability Index [PR Newswire] - Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones Sustainability World Indexes and North America Indexes . us.rd.yahoo.com |
PPD Opens Office in Novosibirsk, Russia [Business Wire] - WILMINGTON, N.C.----PPD, Inc. today announced it has opened an office in Novosibirsk, Russia, building on the growth of its Phase II-IV clinical development services in Eastern Europe. us.rd.yahoo.com |